Zivo Bioscience Inc (ZIVO)
7.98
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Zivo Bioscience Enterprise Value: 23.16M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 23.16M |
May 16, 2024 | 23.16M |
May 15, 2024 | 23.16M |
May 14, 2024 | 22.74M |
May 13, 2024 | 22.74M |
May 10, 2024 | 22.74M |
May 09, 2024 | 20.32M |
May 08, 2024 | 22.96M |
May 07, 2024 | 21.58M |
May 06, 2024 | 22.71M |
May 03, 2024 | 22.71M |
May 02, 2024 | 22.71M |
May 01, 2024 | 22.71M |
April 30, 2024 | 22.71M |
April 29, 2024 | 18.92M |
April 26, 2024 | 23.27M |
April 25, 2024 | 22.99M |
April 24, 2024 | 22.99M |
April 23, 2024 | 22.99M |
April 22, 2024 | 22.99M |
April 19, 2024 | 22.99M |
April 18, 2024 | 22.99M |
April 17, 2024 | 19.90M |
April 16, 2024 | 19.65M |
April 15, 2024 | 22.99M |
Date | Value |
---|---|
April 12, 2024 | 22.99M |
April 11, 2024 | 22.88M |
April 10, 2024 | 22.88M |
April 09, 2024 | 22.88M |
April 08, 2024 | 22.88M |
April 05, 2024 | 22.85M |
April 04, 2024 | 22.85M |
April 03, 2024 | 22.88M |
April 02, 2024 | 21.48M |
April 01, 2024 | 21.48M |
March 31, 2024 | 22.18M |
March 28, 2024 | 21.49M |
March 27, 2024 | 21.71M |
March 26, 2024 | 22.19M |
March 25, 2024 | 22.43M |
March 22, 2024 | 24.46M |
March 21, 2024 | 24.41M |
March 20, 2024 | 24.46M |
March 19, 2024 | 24.47M |
March 18, 2024 | 24.47M |
March 15, 2024 | 24.66M |
March 14, 2024 | 24.69M |
March 13, 2024 | 24.24M |
March 12, 2024 | 23.85M |
March 11, 2024 | 21.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.7675M
Minimum
Nov 28 2023
75.35M
Maximum
Jan 07 2021
35.41M
Average
29.42M
Median
Sep 07 2022
Enterprise Value Benchmarks
NovaBay Pharmaceuticals Inc | 5.156M |
Palatin Technologies Inc | 22.26M |
iBio Inc | 16.77M |
Theriva Biologics Inc | -8.901M |
Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.278M |
Revenue (Quarterly) | 0.0357M |
Total Expenses (Quarterly) | 1.312M |
EPS Diluted (Quarterly) | -0.47 |
Gross Profit Margin (Quarterly) | 35.00% |
Profit Margin (Quarterly) | -3.58K% |
Earnings Yield | -47.62% |
Normalized Earnings Yield | -47.62 |